Thermo Fisher Scientific (TMO) Cost of Revenue (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Cost of Revenue for 18 consecutive years, with $3.3 billion the latest figure, recorded in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $3.3 billion, up 4.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.0 billion (up 1.66% YoY), and the FY2025 annual result was $12.9 billion, up 2.05% from the prior year.
• Cost of Revenue was $3.3 billion for Q1 2026 at Thermo Fisher Scientific, up from $3.2 billion in the prior quarter.
• Over five years, Cost of Revenue peaked at $3.7 billion in Q4 2023 and troughed at $2.9 billion in Q4 2022.
• Average Cost of Revenue over 5 years is $3.3 billion, with a median of $3.2 billion recorded in 2023.
• Year-over-year, Cost of Revenue soared 14305.0% in 2022 and declined 9.06% in 2023.
• Over 5 years, Cost of Revenue stood at $3.7 billion in 2022, then climbed by 1.39% to $3.7 billion in 2023, then declined by 7.18% to $3.5 billion in 2024, then declined by 6.78% to $3.2 billion in 2025, then climbed by 0.96% to $3.3 billion in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $3.3 billion in Q1 2026, $3.2 billion in Q4 2025, and $3.3 billion in Q3 2025.